The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Curtis Geoffrey M. since 2016.
This trader's CIK number is 1667903.
At the time of last reporting, Curtis Geoffrey M. was the EVP, Corporate Affairs, CCO of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP).
Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | HZNP | 0 | $0 | 70,739 | $6,615,086 | 75,641 | $1,048,025 |
| 2020 | HZNP | 0 | $0 | 21,918 | $1,092,612 | 25,205 | $0 |
| 2019 | HZNP | 0 | $0 | 39,524 | $966,543 | 49,944 | $0 |
| 2018 | HZNP | 0 | $0 | 9,904 | $204,359 | 30,000 | $0 |
| 2016 | HZNP | 0 | $0 | 0 | $0 | 7,000 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-01 | HZNP | Option Ex | 37,000 | 28.32 | 1,048,025 |
| 2021-04-01 | HZNP | Sale | 70,739 | 93.51 | 6,615,086 |
| 2021-01-21 | HZNP | Option Ex | 3,760 | .00 | 0 |
| 2021-01-05 | HZNP | Option Ex | 34,881 | .00 | 0 |
| 2020-05-26 | HZNP | Sale | 21,918 | 49.85 | 1,092,612 |
| 2020-01-05 | HZNP | Option Ex | 25,205 | .00 | 0 |
| 2019-08-08 | HZNP | Sale | 20,609 | 26.58 | 547,828 |
| 2019-08-01 | HZNP | Option Ex | 30,000 | .00 | 0 |
| 2019-04-08 | HZNP | Option Ex | 7,000 | .00 | 0 |
| 2019-02-25 | HZNP | Sale | 10,080 | 21.22 | 213,867 |
| 2019-02-05 | HZNP | Sale | 8,835 | 23.19 | 204,848 |
| 2019-01-05 | HZNP | Option Ex | 12,944 | .00 | 0 |
| 2018-08-16 | HZNP | Sale | 9,904 | 20.63 | 204,359 |
| 2018-08-01 | HZNP | Option Ex | 30,000 | .00 | 0 |
| 2016-04-08 | HZNP | Option Ex | 7,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Curtis Geoffrey M. (EVP, Corporate Affairs, CCO of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.